$PFE gets a May 2023 PDUFA for its RSV vaccine in older adults.
https://t.co/HgQFcONltH
$GSK also has a May decision date from the FDA for its rival RSV vaccine in older adults.
BioCentury's latest biopharma Quick Takes: Apellis’ Syfovre first to market for geographic atrophy. Plus: Amid partnership talks, Madrigal also ‘open’ to M&A; and updates from Panakès, Aqilion-Merck KGaA, Pfizer, Merck & Co. $APLS $MDGL $MRK $PFE $VALN https://t.co/t7cDeKLAnd
Turn your @Figma designs into interactive websites with #Vev — without coding a thing. Learn more: https://t.co/jxRH9fp6CTurn your @Figma designs into interactive websites with #Vev — without coding a thing. Learn more: https://t.co/jxRH9fp6CTurn your @Figma designs into interactive websites with #Vev — without coding a thing. Learn more: https://t.co/jxRH9fp6CTurn your @Figma designs into interactive websites with #Vev — without coding a thing. Learn more: https://t.co/jxRH9fp6CTurn your @Figma designs into interactive websites with #Vev — without coding a thing. Learn more: https://t.co/jxRH9fp6CTurn your @Figma designs into interactive websites with #Vev — without coding a thing. Learn more: https://t.co/jxRH9fp6CO
🎉 The Sinverse team is proud to sponsor #NFTNYC2023 💎 alongside the likes of @opensea and @Immutable
Join us in 📅 April 2023 for the biggest #NFT convention in the Big Apple 🗽🍎 for the latest reveals and more 🔥
$SIN $IMX #Metaverse
Whenever someone says that you got lucky buying Bitcoin, show them this chart.
HODLing Bitcoin is not easy; you must have a tremendous amount of belief to hold through multiple 70%+ drawdowns.
The market will test everyone's conviction & BTC's volatility is a mechanism to transfer supply to the strongest hands.